The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to access the efficacy and safety of MC2-25 cream and MC2-25
vehicle for treatment of chronic kidney disease associated pruritus (CKD)-aP).